In what looks to be the largest follow-on stock offering in biopharma history, US oncology company Revolution Medicines ...

German innovation hub BioMed X has launched its first research team in France, partnering with French pharma Servier to ...

US-based Sonire Therapeutics has secured $18 million in Series A financing to advance clinical development of its ...

German drugmaker Bayer (BAYN: DE) has highlighted publication of full results from its Phase III OCEANIC-STROKE trial in the ...

The US Food and Drug Administration will ask outside advisers in July whether some peptide substances should be allowed on ...

UK-based specialty pharma company CNX Therapeutics today announced the appointment of David Flint as chief corporate ...

Privately-held Swiss drug firm Ewopharma has reported that sugemalimab, licensed from Chinese partner CStone Pharmaceuticals, ...

A biotechnology company, based in France, developing protein-based therapeutics for immunologicals with a focus on addressing ...

New research from researchers at the University of Florida, University of Maryland and Yale School of Public Health has found that if measles, mumps and rubella (MMR) immunization rates continue to ...

Enodia Therapeutics, a privately-held French biotech developing small molecule therapies targeting a unique form of protein ...

US clinical-stage biotechnology company Beeline Medicines today announced its official debut with the mission of developing ...

Johnson & Johnson has announced its financial results for the first quarter of 2026.